| Tag | Content |
|---|
EnhancerAtlas ID | HS073-04078 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr14:64700910-64701680 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ZNF263 | MA0528.1 | chr14:64701019-64701040 | CCCCTCCCCTCCTCCAGCTCC | - | 6.37 | | ZNF263 | MA0528.1 | chr14:64701008-64701029 | CCTTCCACCCTCCCCTCCCCT | - | 6.63 | | ZNF263 | MA0528.1 | chr14:64701013-64701034 | CACCCTCCCCTCCCCTCCTCC | - | 6.98 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_10782 | chr14:64700800-64703816 | CD19_Primary | | SE_58342 | chr14:64635418-64706815 | Ly1 | | SE_59566 | chr14:64660997-64704625 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr14 | 64701131 | 64701352 | | chr14 | 64700944 | 64701061 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH14I064234 | chr14 | 64700805 | 64703691 |
|
Enhancer Sequence | GGGAAAGGCA GAGGTCTTCA TCTCACTTAA GATTCTCGAG GTGTATATTG TCCTTCTCCA 60
CAGCCTCTAG ACTTGCCTCC TCAGTGACCA GTTAATTACC TTCCACCCTC CCCTCCCCTC 120
CTCCAGCTCC AGGGCAAGGC TACCCTCATC GTGGGTGACA CCAAGCACTG AGCATCATTG 180
TACCAACAGT AGCCACCACT GCACACCCTC TTCATCAGCA CACACAATTA CGTTTCCTGA 240
TCAGAAACAT GCCCTACCTA CAGCCCTGCC TTCCTAAATC TGCTGGGTCC ACCACTTCTC 300
TTAAGTCTTA TCCTTAATTT CCTGATGCCA CCGAAAGAAC AACTCTTAGG GAAGCATTTG 360
TGCACTTCTT CGCATCACCA GCTCGAGGGG CCATCTAGGG GAGCGGGTCT TAGCCTCTCC 420
ACAAAAAGTG GCCTCAGGGC CTCAGCCCTG GGTGGTGTAA ACAGGGGTGG CAGTTCGTGT 480
TAGGGGAGGA ACTGCCCCTT TTAGGACTCC ATAAACAGGC TATAAACCCC AGCAATTGAA 540
AAACCCATGA GCCACCACTG GCTGCCATGC AGAGCCTGTA AGATACCACA TGACATTCCT 600
TCCATGCCCA CTCTGTGCCC ATCTTTGCTT ACAGGTGTGT GAACTGACAA ATTCCCCATT 660
CCCTTTCAGG CATTCATTTT CCTTAACTTG CAGACACTTT TCCCAAATCA CTTCACCCTC 720
CGTGGAGCAC ATAATCCCAT CCCAAGCCCA AGCAGAGCAG CTCCTTAGGG 770
|
